Skip to main content

Table 1 Characteristics of four patients

From: SGLT-2 inhibitors may increase ultrafiltration in incident peritoneal dialysis patients: a case report

 

Case 1

Case 2

Case 3

Case 4

Age year

52

48

57

42

Gender

Male

Female

Male

Female

Blood pressure mmHg

182/110

148/92

174/105

165/92

Height cm

152

165

168

158

Weight kg

82

74

103

65

Body mass index kg/m2

35.5

26.1

36.5

26.0

Uremic symptoms

Acute pulmonary edema

Nausea, vomiting

Acute pulmonary edema

Hyperkalemia

Cause of CKD

Diabetes

Diabetes

Diabetes

IgA nephritis

Comorbidity

CAD, CHF, dyslipidemia

-

CAD

-

Before/After

 Venous pH

7.12/7.32

7.18/7.28

7.20/7.35

7.11/7.33

 Hemoglobin g/dl

9.6/10.2

8.7/9.8

10.2/10.8

9.2/10/6

 BUN mg/dl

175/98

102/85

140/92

172/87

 Creatinine mg/dl

16.5/10.2

14.2/9.8

15.8/9.2

18.4/9.5

 Calcium mg/dl

8.9/8.9

8.7/8.6

8.5/8.7

7.9/8.2

 Phosphate mg/dl

6.5/5.8

3.7/4.3

6.8/5.2

3.8/4.5

 Sodium meq/L

142/141

141/141

138/139

137/136

 Potassium meq/L

6.2/4.8

4.5/4.2

6.5/3.8

7.2/5.4

 Glucose mg/dl

185/162

178/152

194/135

102/98

 Modality

Automated

Automated

Automated

CCPD

PET

 D/P

0.96

0.88

0.94

0.86

 D/D0

0.18

0.24

0.22

0.19

 Dialysate sodium meq/L

127

128

125

126

 Follow-up days

15

5

8

5

 Anti-diabetic drug

Lantus 16u qd

Linagliptin 1# qd

Lantus 20u qd

 

Ultrafiltration ml/day

 Basal

920 ± 257

740 ± 322

1142 ± 236

854 ± 385

 After SGLT2

1260 ± 156

1140 ± 245

1485 ± 220

1267 ± 288

Urine ml/day

 Basal

580 ± 220

1200 ± 480

220 ± 120

780 ± 530

 After SGLT2

640 ± 180

1120 ± 350

320 ± 150

850 ± 250

 Weight on discharge kg

72

68

87

59

  1. CKD Chronic kidney disease, CAD Coronary-artery disease, CHF Congestive heart failure, BUN Blood urea nitrogen, PET Peritoneal equilibration test, CAPD Continuous ambulatory peritoneal dialysis, CCPD Continuous cycling peritoneal dialysis, SGLT-2 Sodium-glucose cotransporter-2